Previous close | 21.03 |
Open | 21.61 |
Bid | 15.21 x 200 |
Ask | 25.98 x 200 |
Day's range | 20.26 - 21.64 |
52-week range | 18.61 - 30.52 |
Volume | |
Avg. volume | 696,767 |
Market cap | 1.549B |
Beta (5Y monthly) | N/A |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Veracyte's (VCYT) first-quarter 2024 performance reflects the strength of its testing business.
Explore key insights from Veracyte's Q1 2024 earnings, including significant revenue growth, testing volume records, and strategic expansions.